Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 219684
Company: BAXTER HLTHCARE CORP
Company: BAXTER HLTHCARE CORP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| KETAMINE HYDROCHLORIDE | KETAMINE HYDROCHLORIDE | EQ 100MG BASE/10ML (EQ 10MG BASE/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | Prescription | None | No | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 09/17/2025 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |